This inventor holds 1 USPTO granted patent. Top assignees: Albert Einstein College of Medicine, Massachusetts Institute of Technology. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 1999
Title: Ken Julian Takekoshi: Innovator in Cell Transformation Technologies
Introduction
Ken Julian Takekoshi is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of cell transformation, particularly through his innovative methods and compositions that enhance the efficiency and stability of transgene integration.
Latest Patents
Takekoshi holds a patent for "Methods and compositions for transforming cells." This patent discloses techniques that result in efficient and stable site-specific integration of transgenes. The transformation process involves introducing an acceptor vector, preferably a retroviral vector, into a cell, which integrates into the cell's genome. The acceptor vector contains two incompatible lox sequences, L1 and L2. Subsequently, a donor vector is introduced, which comprises a transgene flanked by the same L1 and L2 sequences. Stable gene transfer is initiated by the interaction of the lox L1 and L2 sequences with Cre recombinase.
Career Highlights
Throughout his career, Takekoshi has worked with prestigious institutions, including the Albert Einstein College of Medicine and the Massachusetts Institute of Technology. His work has significantly advanced the understanding and application of gene transfer technologies.
Collaborations
Some of his notable coworkers include Eric Bouhassira and Karen Westerman. Their collaborative efforts have contributed to the success of various projects in the field of cell transformation.
Conclusion
Ken Julian Takekoshi is a prominent figure in the realm of cell transformation technologies, with a patent that showcases his innovative approach to gene integration. His contributions continue to influence the field and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile